NHS
The Shrewsbury and
Telford Hospital
NHS Trust
2021- 2022
The Shrewsbury and Telford Hospital
NHS Trust Charity
Registered Charity 1107883
ShrÈvtsburyand
Tellord Hospjtal
charity
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Unrestricted|funds|f355,000|
|---|---|---|
|One year's|administration,|f34,000|
|fundraising|and support||
|costs|||
|Free Reserves||F321,000|
##
##
##
##
##
##
|Investment|managers|CCLA Investment|CCLA Investment|Senator House, 85 Queen|
|---|---|---|---|---|
|||Management|Ltd|Victoria Street, London,|
|||||EC4V4ET|
|Independent|Examiners|Dyke Yaxley||1 Brassey Road, Old Potts|
|||||Way, Shrewsbury,
SY37FA|
|Bankers||The Royal Bank ofScotland||1 Redheughs
Avenue,|
|||pic||Edinburgh,
EH12 9JN|
|Legal advisors||Hill Dickinson|LLP|Pearl Assurance
House|
|||||Derby Square,
Liverpool|
|||||L2 9XL|
|During the year,|the following|voting directors
held office:||||
|---|---|---|---|---|---|
|Chair||Dr Catriona
McMahon||||
|Chief Executive||Louise Barnett||||
|Non-Executive|Director|Teresa Boughey||||
|||Anthony
Bristlin||||
|||David Brown||||
|||Prof. Clive Deadman||||
|||Dr David Lee||||
|||Prof. Trevor Purt||||
|Medical Director||DrArne Rose|to30.09.2021|||
|||John Jones|from 01.10.2021|||
|Director of Nursing||Hayley
Flavell|secondment||from University|
||||Hospital|Birmingham||
|Chief Operating|Officer|Nigel Lee|to 13.03.2022|||
|||Sara Biffen (Acting)|from 14.03.2022|||
|Director ofFinance||Helen Troalen||||
|Associate|Non-Executive|Directors|Rajinder|Dhaliwal|from 01.05.2022|
|---|---|---|---|---|---|
||||Professor|Julie Green|from 01.05.2022|
||||Rosi Edwards||from 01.06.2022|
##
|Chair|Teresa Boughey|
|---|---|
|Non-Executive
Director|Prof Clive Deadman|
||Prof Trevor Purt|
|Director of Finance|Helen Troalen|
|Director of Public Participation|Julia Clarke|
##
##
##
##
##
##
##
##
##
##
##
##
##
|Statement of Financial Activities|for the yea|r ending 3|1March|2022||||
|---|---|---|---|---|---|---|---|
||Note|'oe
8
e
e ~
2 u.|'oe-"e
« '0
e c
QC u|e
c
u-
Ta cv
«CV
0o
I- ol|'o
Q9
e e
e c
C0 u|e
tO0
8ec' u|VPc
u
e0 O|
|||f000|f000|f000|f000|f000|f000|
|Income from||||||||
|Donations
and legacies||30|281|311|191|306|499|
|NHS Charities Together||0|335|335|0|180|180|
|Investments||7|30|37|10|35|45|
|Total incoming resources||37|646|683|201|523|724|
|Expenditure
on||||||||
|Charitable
activities|9|(107)|(326)|(433)|(90)|(416)|(506)|
|NHS Charities Together||0|(178)|(178)|0|(63)|(63)|
|Total expenditure||(107)|(504)|(611)|(90)|(479)|(569)|
|Net incomel (expenditure)||(70)|142|72|111|44|155|
|Net gains/ (losses) on investments||(86)|0|(86)|(11)|(8)|(19)|
|Net Movement
in funds||(168)|142|(24)|100|36|135|
|Reconciliation
of Funds||||||||
|Total Funds brought
forward|22|521|1,743|2,264|421|1,707|2,218|
|Total Funds carried forward|22|355|1,885|2,240|521|1,743|2,264|
##
|Balance Sheet as at 31March 2|022|||||||
|---|---|---|---|---|---|---|---|
||Note|'u
Cl
V
IVe~
e
C|'oe0 e
l0 C
e
IX IL|ec
IL
8 IV
cv
oo
I-cv|/9
C
e o
Du|e
VJD
0 c
e
IE: u|~0
IL
0 CI
I- Cv|
|||5000|5000|5000|k000|OOOO|f000|
|Fixed assets||||||||
|Investments|16|315|1,885|2,200|534|1,750|2,284|
|Total Fixed Assets||315|1,885|2,200|534|1,750|2,284|
|Current assets||||||||
|Debtors|17|0|1|1|0|2|2|
|Cash at bank and in hand|18|40|15|55|11|36|47|
|Total Current Assets||40|15|56|11|38|49|
|Liabilities||||||||
|Creditors falling due within one|19|0|(16)|(16)|(24)|(45)|(69)|
|year||||||||
|Net Current assets/(liabilities)||40|0|40|(13)|(7)|(20)|
|Total net assets or liabilities||355|1,885|2,240|521|1,743|2,264|
|The funds ofthe charity:|22|||||||
|Unrestricted
income funds:||355|0|355|521|0|521|
|Restricted income funds||0|1,885|1,885|0|1,743|1.743|
|Total charity funds||355|1,885|2,240|521|1,743|2,264|
##
|||||||||Total|Total|
|---|---|---|---|---|---|---|---|---|---|
||||||||Note|Funds|Funds|
|||||||||2022|2021|
|||||||||2000|f000|
|Cash flows from||operating|activities|||||||
|Net cash|provided|by (used|in) operating||activities||20|(17)|176|
|Cash flows from||investing|activities|||||||
|Dividends|and interest from||investments||||7|37|45|
|Sale of investments|||||||16|0|0|
|Purchase|ofinvestments||||||16|(12)|(220)|
|Net cash|provided|by (used in) investing||||activities||25|(175)|
|Change
in cash and cash equivalents||||in|the|reporting||||
|period||||||||||
|Cash and|cash equivalents||at beginning||ofthe||18|47|46|
|reporting|period|||||||||
|Cash and|cash equivalents||at the end||of|the||55|47|
|reporting|period|||||||||
##
##
|3.
Income from|donations
and legacies||||||||
|---|---|---|---|---|---|---|---|---|
|||'O|||||||
|||4I
V~
CA
4I
D|CI
~
u|4I
Tl
CC
4I
tt.'u|CI
u
CV
8 CV
0 CI
i
CV|o
4I9c
III
N
4I
L2 LL|4I
CR
v D
III
4I
EL u|M
LL
CC0 CI
i—CII|
|||fOOO||fOOO|fOOO|f000|f000|f000|
|Donations|||18|256|272|149|266|415|
|Legacies|||14|25|39|42|42|84|
|Total|||30|281|311|191|308|499|
||||||'00|CO
'D
C|O!
O|'0
CO|CO
C|
|---|---|---|---|---|---|---|---|---|---|
||||LO|LO|0
LO0
IX,'u.|u.
CO
OC
8 CV
0 C0
I- OI|CO
CO
I C
CDu|CO
+ '0
N
CO
IX. LL|LL
CV
CO0 O|
||||8000||f000|f000|FOOO|f000|f000|
|NHS|Charities|Together||0|335|335|0|180|180|
|Total||||0|335|335|0|180|180|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|7.|Gross investment|income|LO
OC
Ol
CD|Ol
C
IL|'0
Ol
Co
CO
0
IL|OI
C
IL|lO'0
C
Iu
CO
8
0
I|CV
OC
CO
OC|'0
Ol
g
CO
CDu|'08
Ol0K|CO'0
u|Vl'0
C
LL
CO0 O
I- OC|
||||ROOO||FOOO||FOOO||F000|OOOO||OOOO|
|Fixed|asset investments|||7||30||37|10||35|45|
|Total||||7||30||37|10||35|45|
||||Activities|Support|Total|
|---|---|---|---|---|---|
||||undertaken|Costs|2022|
||||directly|||
||||f000|f000|f000|
|NHS Charities|Together|- Grants|177|1|178|
|NHS Charities|Together|- Patient welfare|124|1|125|
|and amenities||||||
|Patient welfare|and amenities||227|28|255|
|Staff welfare and amenities|||37|3|40|
|Staff education,|training|and development|12|1|13|
|Total|||577|34|611|
||||Activities|Support|Total|
||||undertaken|Costs|2021|
||||directly|||
||||f000|f000|f000|
|NHS Charities|Together|- Grants|62|1|63|
|NHS Charities|Together|- Patient welfare|63|1|64|
|and amenities||||||
|Patient welfare|and amenities||260|21|281|
|Staff welfare and amenities|||123|8|131|
|Staff education,|training|and development|29|1|30|
|Total|||537|32|569|
##
|||Activities|Support|Total|
|---|---|---|---|---|
|||undertaken|Costs|2022|
|||directly|||
|||f000|f000|f000|
|Opening|balance at 1 April 2021 (see note 19)|69|0|69|
|Additional|commitments
made during the year|577|0|577|
|Amounts|paid during the year|(630)|0|(630)|
|Closing|balanceat1April2022(seenote19)|16|0|16|
|||Activities|Support|Total|
|---|---|---|---|---|
|||undertaken|Costs|2021|
|||directly|||
|||f000|f000|f000|
|Opening|balance at 1 April 2020 see note 19)|7|0|7|
|Additional|commitments
made during the year|537|0|537|
|Amounts|paid during the year|(475)|0|(475)|
|Closing|balance at 1 April 2021 (see note 19)|69|0|69|
||||||||Total|Total|
|---|---|---|---|---|---|---|---|---|
||||||||2022|2021|
||||||||f000|f000|
|Independent||Examination||fees|||3|2|
|Governance|||||||3|2|
|Salaries and||related costs|||||29|28|
|Just Giving/Cash|||carrier/Bank||charges||1|1|
|Software Support|||||||1|1|
|Total|||||||34|32|
|||||||Unrestricted|Restricted|Total|
|||||||Funds|Funds|2022|
|||||||f000|f000|f000|
|Charitable|activities|||||7|27|34|
|Total||||||7|27|34|
|||||||Unrestricted|Restricted|Total|
|||||||Funds|Funds|2021|
|||||||f000|f000|f000|
|Charitable|activities|||||7|25|32|
|Total||||||7|25|32|
||||Total|Total|
|---|---|---|---|---|
||||2022|2021|
||||f000|f000|
|Salaries and wages|||24|23|
|Social security costs|||2|2|
|Employers|pension|contribution|3|3|
|Total|||29|28|
##
##
##
|16.Fixed asset investments|||
|---|---|---|
||Total|Total|
|Movement
in fixed asset investments|2022|2021|
||f000|f000|
|Market value brought
forward
Deposits from Royal Bank ofScotland account
Dividends
and interest|2,284
125
37|2,083
175
45|
|Withdrawals
to Royal Bank ofScotland account|(150)|0|
|Add net gain/(loss)
on revaluation|(96)|(19)|
|Market value as at 31 March|2,200|2,284|
##
|Fixed ass|et investmen|ts
by type|||||
|---|---|---|---|---|---|---|
||||Units held as|Units held as|Total|Total|
||||at 31 March|at 31 March|2022|2021|
||||2022|2021|||
||||OOOO|f000|6000|LOOO|
|Common|investment|funds|||||
|Deposit Fund|||||949|938|
|Fixed Interest Account|||999,226|999,226|1,251|1.346|
|Total|||||2,200|2,284|
|17.Analysis|ofcurrent debtors|||
|---|---|---|---|
|Debtors under 1year||Total
2022|Total
2021|
|||6000|6000|
|Accruals for|income owed to the Charity at 31 March|1|2|
|Total||1|2|
|18.A|nalysis|ofcash and cash equivalents|||
|---|---|---|---|---|
||||Total|Total|
||||2022|2021|
||||OOOO|OOOO|
|Royal|Bank|of Scotland accounts|55|47|
|Total|cash|and cash equivalents|55|47|
|19.Analysis|19.Analysis|of liabilities|of liabilities|Total|Total|
|---|---|---|---|---|---|
|||||2022|2021|
|Creditors|under||1 year|||
|||||f000|f000|
|Trade Creditors||||13|65|
|Accruals|for|sums|owed by the Charity at 31 March|3|4|
|Total||||16|69|
|20. Reconciliation
o|fne|t income/(expenditure|)|to net cash|flow from oper|ating
activitie|s|
|---|---|---|---|---|---|---|---|
|||||||Total|Total|
|||||||2022|2021|
|||||||6000|OOOO|
|Net income/(expenditure)||as per the statement||offinancial|activities|(24)|136|
|Adjustments
for:||||||||
|(Gains)/losses
on investments||||||96|19|
|Dividends
and interest||from investments||||(37)|(45)|
|(Increase) /decrease|in|debtors||||1|4|
|Increase/(decrease)|in|creditors||||(53)|62|
|Net cash provided|by|(used in) operating|activities|||(17)|176|
##
##
|||||Balance|Income|Expenditure|Balance|
|---|---|---|---|---|---|---|---|
|||||b/fwd|||c/fwd|
|||||f000|f000|f000|6000|
|Shropshire
Haematology|||Blood Research|403|44|(18)|429|
|Ward 23 Haematology/Oncology||||158|7|(12)|153|
|Sub-Specialty|Cancer Fund|||154|13|(39)|128|
|Breast Cancer|Fund|||100|27|(5)|122|
|NHS Charities|Together|||54|337|(303)|88|
|Respiratory
RSH||||64|13|(1)|76|
|Stroke - Ward|21,Ward||22R|53|9|(1)|61|
|Cardiology||||50|9|(2)|57|
|Lottery Small Differences||||53|39|(41)|51|
|Chemotherapy|Day Centre|||43|8|(1)|50|
|Renal/Nephrology||||21|28|(1)|48|
|ITU RSH||||56|8|(24)|40|
|Pharmacy||||37|5|(3)|39|
|Diabetes
Hummingbird||Centre||37|1|0|38|
|Elderly Care Patients||||35|9|(7)|37|
|ITU PRH||||17|19|(1)|35|
|Children's
Oncology||||24|7|0|31|
|Endoscopy||||20|4|(1)|23|
|Hamar Centre||||23|0|(1)|22|
|Vascular||||22|2|(2)|22|
|Urology||||20|2|0|22|
|Neonatal
Unit||||20|7|(6)|21|
|Children's
Unit||||20|2|(2)|20|
|AMU RSH||||18|1|0|19|
|Colorectal||||17|1|0|18|
|Swan Fund||||16|9|(8)|17|
|Radiotherapy
Head and Neck General||||16
2|0
14|0
0|16
16|
|Midwife Led Units||||14|0|0|14|
|Respiratory
PRH||||11|3|(2)|12|
|Audiology||||20|0|(9)|11|
|A&E RSH||||10|1|0|11|
|Other funds below f10k|||(32funds)|135|17|(14)|138|
|Total||||1,743|646|(504)|1,885|
##
##
||||Balance|Income|Expenditure|Balance|
|---|---|---|---|---|---|---|
||||b/fwd|||c/fwd|
||||FOOD|f000|f000|6000|
|Shropshire
Haematology||Blood Research|411|56|(64)|403|
|Ward 23 Haematology/Oncology|||150|17|(9)|158|
|Sub-Specialty|Cancer Fund||207|4|(57)|154|
|Breast Cancer|Fund||94|10|(4)|100|
|Respiratory
RSH|||61|6|(3)|64|
|ITU RSH|||37|29|(10)|56|
|NHS Charities|Together||0|181|(127)|54|
|Stroke - Ward|21,Ward|22R|52|2|(1)|53|
|Lottery Small Differences|||15|70|(32)|53|
|Cardiology|||61|4|(15)|50|
|Chemotherapy|Day Centre||21|24|(2)|43|
|Diabetes
Hummingbird||Centre|40|1|(4)|37|
|Pharmacy|||32|5|0|37|
|Elderly Care Patients|||32|5|(2)|35|
|Children's
Oncology|||26|1|(3)|24|
|Hamar Centre|||31|2|(10)|23|
|Vascular|||31|1|(10)|22|
|Renal/Nephrology|||42|5|(26)|21|
|Neonatal
Unit|||39|4|(23)|20|
|Audiology|||58|1|(39)|20|
|Endoscopy|||22|1|(3)|20|
|Children's
Unit|||14|8|(2)|20|
|Urology|||10|10|0|20|
|AMU RSH|||3|15|0|18|
|ITU PRH|||15|6|(4)|17|
|Colorectal|||10|7|0|17|
|Swan Fund|||17|6|(7)|16|
|Radiotherapy|||11|11|(6)|16|
|Midwife Led Units|||13|0|0|13|
|MSKT80 RSH|||12|1|(2)|11|
|Respiratory
PRH|||10|1|0|11|
|A8E RSH|||7|3|0|10|
|Other funds below F10k(35funds)|||123|26|(22)|127|
|Total|||1,707|523|(487)|1,743|
##
|(c)|Analysis|of unrestricte|d
fund movement|s
2022||||
|---|---|---|---|---|---|---|---|
||||Balance|Income|Expenditure|Unrealised|Balance|
||||b/fwd|||Loss|c/fwd|
||||f000|f000|f000|f000|f000|
|SaTH|General|Fund|521|37|(107)|(96)|355|
|Total||||||||
|(d)|Analysis|Analysis||of unrestricted|fund movements|2021||||
|---|---|---|---|---|---|---|---|---|---|
|||||||Balance|Income|Expenditure|Balance|
|||||||b/fwd|||c/fwd|
|||||||f000|f000|f000|f000|
|SaTH|General||Fund|||413|201|(93)|521|
|Unrealised||Gain||Reserve||8|0|(8)|0|
|Total||||||421|201|(101)|521|
|||||COIF|COIF Fixed|Total|
|---|---|---|---|---|---|---|
|||||Deposits|interest||
|||||f000|f000|f000|
|Opening|Balance|as at 1 April 2021||938|1,346|2,284|
|Transfer|between|COIF and|RBS|(25)|0|(25)|
|Dividends|Received|||0|36|36|
|Dividends|transfer|between|funds|36|(36)|0|
|Interest Received||||0|1|1|
|Unrealised
Investment
Gain/(Loss)||||0|(96)|(96)|
|Closing Balance as at 31 March 2022||||949|1,251|2,200|
|||||COIF|COIF Fixed|Total|
|||||Deposits|interest||
|||||6000|OOOO|OOOO|
|Opening|Balance|as at 1 April 2020||718|1,365|2,083|
|Transfer|between|COIF and|RBS|175|0|175|
|Dividends|Received|||0|45|45|
|Dividends|transfer|between|funds|45|(45)|0|
|Interest Received||||0|0|0|
|Unrealised
Investment
Gain/(Loss)||||0|(19)|(19)|
|Closing Balance as at 31 March 2021||||938|1,346|2,284|